复方异丙托溴铵联合布地奈德雾化吸入治疗对老年慢性阻塞性肺疾病患者血气指标的影响

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of Compound Ipratropium Bromide combined with Budesonide atomization inhalation on blood gas indexes in elderly patients with chronic obstructive pulmonary disease (COPD). Methods A total of 80 COPD elderly patients admitted to Xuzhou First People′s Hospital from January 2019 to January 2021 were selected as the study subjects,and were divided into study group (40 cases) and control group (40 cases) by random number table method. The study group received Compound Ipratropium Bromide combined with Budesonide, and the control group received Budesonide, the treatment course was 7 d. The difference in dynamic venous oxygen content (Ca-jvO2),oxygenation index (PaO2/FiO2), 6-minute walking test (6MWT), oxygen saturation (SaO2), BODE index score and the occurrence of adverse reactions were compared between two groups before and after treatment. Results Before treatment,there was no significant difference in SaO2,Ca-jvO2 and PaO2/FiO2 levels between the two groups(P＞0.05).After treatment,the levels of SaO2 and PaO2/FiO2 in the study group were higher than those in the control group, while the levels of CajvO2 were lower than those in the control group,with statistical significances(P＜0.05).There were no significant differences in 6MWT and BODE index between the two groups before treatment (P＞0.05). After treatment, the 6MWT of the study group was higher than that of the control group, and the BODE index was lower than that of the control group, with statistical significances (P＜0.05). No serious adverse reactions occurred in two groups during treatment, and there was no statistical significance in the total incidence of adverse reactions between two groups (P＞0.05). Conclusion Compound Ipratropium Bromide combined with Budesonide atomization inhalation can effectively improve the blood gas indexes and exercise endurance of elderly patients with COPD.

Key words： Chronic obstructive pulmonary disease;Compound Ipratropium Bromide Budesonide Blood gas analysis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Ying
	LIU Yan

Cite this article:

ZHANG Ying,LIU Yan. Effect of Compound Ipratropium Bromide combined with Budesonide atomization inhalation on blood gas indexes in elderly patients with chronic obstructive pulmonary disease[J]. 中国当代医药, 2022, 29(16): 79-82.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I16/79

[1]	孙宁，崔红生.桑梅止咳颗粒联合布地奈德，复方异丙托溴铵治疗老年AECOPD 的疗效及对IL-17，HIF-1α 的影响[J].现代中西医结合杂志，2021，30（5）：479-482,534.
[2]	张子洲，钱璞，沈科.布地奈德福莫特罗粉吸入剂联合血必净治疗慢性阻塞性肺疾病患者的临床研究[J].中国临床药理学杂志，2019，16（7）：133-135.
[3]	王娟，马菁菁.复方异丙托溴铵雾化吸入联合百令胶囊治疗AECOPD 患者的效果及机制[J].中南医学科学杂志，2019，47（5）：465-468.
[4]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南（2013年修订版）[J].中华结核和呼吸杂志，2013（4）：255-264.
[5]	何彦侠，薛兵.6MWT 与COPD 患者肺功能的相关性及对患者预后的预测价值[J].西南国防医药，2019，29（1）：27-30.
[6]	马明铭，李芳，杨慧，等.噻托溴胺粉雾剂联合非药物康复方案对慢性阻塞性肺疾病患者BODE 指数的影响[J].陕西医学杂志，2019，48（4）：515-517.
[7]	曹校校，傅安安，陈荣，等.血清高敏C-反应蛋白，肿瘤坏死因子-α 联合肺功能检测在诊断慢性阻塞性肺疾病中的应用价值分析[J].中国卫生检验杂志，2020，30（3）：100-102，105.
[8]	Saito Z，Yoshida M，Kojima A，et al.Benefits and Risks of Inhaled Corticosteroid Treatment in Patients with Chronic Obstructive Pulmonary Disease Classified by Blood Eosinophil Counts[J].Lung，2020，198（6）：1-7.
[9]	戈艳蕾，刘聪辉，余华丽，等.白介素-17 与8-异前列腺素F2α 水平对于慢阻肺患者急性加重风险的诊断效能评价[J].临床肺科杂志，2019，24（4）：67-71.
[10]	周少珠，叶旭军，杨静，等.沙丁胺醇，布地奈德不同雾化吸入联合头孢哌酮钠舒巴坦钠对AECOPD 患者血气指标和肺功能的影响[J].现代生物医学进展，2020，20（8）：1468-1472.
[11]	Yi J，Wang F，Yue R，et al.Effect of sitting and lying Liuzijue for lung rehabilitation in acute exacerbation of chronic obstructive pulmonary disease patients with non-invasive ventilation： Study protocol for a randomized controlled trial[J].Medicine，2020，99（12）：143-145.
[12]	刘晓冬，胡克.特布他林联合糖皮质激素与谷胱甘肽治疗慢阻肺急性加重期的疗效及对患者炎症因子水平的影响[J].河北医学，2020，26（1）：71-75.
[13]	张莉，张永利，达春水.孟鲁司特钠对哮喘-慢阻肺重叠综合征患者肺功能及炎症指标的影响[J].海南医学，2020，31（2）：163-166.
[14]	张磊，李维力，王春.布地奈德混悬液联合异丙托溴铵在COPD 患者中的应用效果及对肺功能的影响[J].中国医药导报，2021，22（5）：139-142.
[15]	朱彦秋，代福恒，侯海龙，等.甲泼尼龙联合布地奈德雾化吸入对AECOPD 患者炎性因子及免疫功能的影响[J].疑难病杂志，2020，19（2）：122-126.
[16]	王宁，栗娜，韩巧玲，等.布地奈德福莫特罗联合噻托溴铵治疗哮喘-慢性阻塞性肺疾病重叠的临床研究[J].中国综合临床，2021，37（1）：39-45.
[17]	余祖滨，卢潇，王静思，等.布地奈德联合异丙托溴铵雾化吸入对围手术期肺癌合并中重度COPD 患者的临床应用研究[J].临床肺科杂志，2019，24（10）：1851-1854.
[18]	陈建波，曹磊，蔡丽婷，等.布地奈德联合异丙托溴铵雾化吸入对慢性阻塞性肺疾病患者肺功能、炎症和血气指标的影响[J].中国医药科学，2020，10（8）：70-73.